Skip to content
SMA Foundation
SMA Patient Resources | Donate Now
  • About Us
    • Overview
    • SMA Foundation Leadership
    • Board of Directors
    • Patient Advisory Board
    • Foundation News
    • Contact Us
  • About SMA
    • Overview
    • Frequently Asked Questions
    • Informational Materials
    • SMA Patient Resources
    • SMA Press
    • Professional Meetings
    • SMA Organizations Worldwide
    • Glossary
    • Donate Now
  • Our Research
    • Overview
    • Drug Discovery
    • Basic & Translational Research
    • Clinical Research
    • Research Funding
    • Reports and Publications
    • SMA Journal Articles
  • Drugs in Development
    • Overview
    • SMA Therapeutics Pipeline
    • Drug Development Process
    • Available Clinical Trials and Drugs
  • Drugs Discovery Assets
    • Overview
    • SMN ELISA
    • Biomarkers
    • SMA-MAP Biomarker Panel
    • In Vitro Tools
    • Animal Models
    • In Vivo Testing
    • Licenses and MTAs
    • Clinical Resources
    • SMA Tissue Repositories
    • Antibodies

Roche to begin Part 2 of the SUNFISH Trial

September 25, 2017

To read the full press release, please click here: SUNFISH

← Scholar Rock to Develop SRK-015 to Improve Muscle Function in Patients with Spinal Muscular AtrophyAveXis Announces Plan to Initiate Pivotal Trial of AVXS-101 in SMA Type 1 Using Product from New GMP Commercial Process →
© 2023 Spinal Muscular Atrophy Foundation. All Rights Reserved. | Contact Us | Terms of Use
Scroll To Top